CIK: 0001816307
申报总市值
US$9.8亿
申报季度: 2026-03-31 · 持股只数: 73
SILVERARC CAPITAL MANAGEMENT, LLC在最新一期 13F 报告中披露了 73 项持股，申报期为 2026-03-31，总持股市值约为 US$9.8亿，季度换手率为 76.0%。
Silverarc Capital Management, LLC 目前披露的持仓，Herfindahl 集中度指数为 0.037——换算下来相当于约 27 个等权重仓位，明显低于其实际披露的 73 只持仓。这一差距显示该机构的策略偏向集中在少数高信心仓位，而非广泛分散。
整体仓位大小差异较大（变异系数为 1.32），除少数重仓仓位外，还有许多规模较小的持仓。
最新申报季度中，并未观察到明显偏向加仓既有大仓位或大举建立新仓位的倾向。
目前行业板块分类约覆盖此投资组合披露价值的 5%；其余部分（例如未匹配板块的标的、期权或其他证券类型）尚未纳入板块分类范围。
减仓 ABVX
-28.3% -US$2324.8万
减仓 GUTS
-82.7% -US$2086.9万
减仓 URGN
-13.6% -US$1369.8万
加仓 ERAS
+40.5% US$2506.1万
减仓 N90064901
-30.6% -US$907.4万
减仓 VCYT
-49.7% -US$926.5万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Spdr Series Trust | 股票-其他 | 10.75% | +10.75% | NEW | |
| 2 | 4XC1 | Kalvista Pharmaceuticals INC | 股票-其他 | 5.91% | +0.47% | +18.51% | |
| 3 | DNTH | Dianthus Therapeutics INC | 股票-其他 | 5.61% | +1.32% | -12.72% | |
| 4 | COGT | Cogent Biosciences INC | 股票-其他 | 5.16% | -0.98% | +5.54% | |
| 5 | CELC | Celcuity INC | 股票-其他 | 4.17% | -1.03% | -4.59% | |
| 6 | IMNM | Immunome INC | 股票-其他 | 4.13% | +0.77% | +64.29% | |
| 7 | KOD | Kodiak Sciences INC | 股票-其他 | 3.86% | -0.11% | -3.05% | |
| 8 | NUVL | Nuvalent Inc-a | 股票-其他 | 3.71% | -0.64% | +13.96% | |
| 9 | ABVX | Abivax Sa-adr | 股票-其他 | 3.44% | -4.47% | -28.34% | |
| 10 | GLUE | Monte Rosa Therapeutics INC | 股票-其他 | 3.36% | +1.12% | +94.55% | |
| 11 | ERAS | Erasca INC | 股票-其他 | 3.06% | +2.38% | +40.55% | |
| 12 | ASND | Ascendis Pharma A/S | 股票-其他 | 2.91% | +1.45% | +153.23% | |
| 13 | URGN | UroGen Pharma Ltd. | 股票-其他 | 2.76% | -2.90% | -13.56% | |
| 14 | RYTM | Rhythm Pharmaceuticals INC | 股票-其他 | 2.72% | +0.70% | +125.08% | |
| 15 | PRAX | Praxis Precision Medicines I | 股票-其他 | 2.35% | — | -13.23% | |
| 16 | ZBIO | Zenas Biopharma INC | 股票-其他 | 2.27% | +2.27% | NEW | |
| 17 | SNDX | Syndax Pharmaceuticals INC | 股票-其他 | 2.12% | +0.24% | +38.28% | |
| 18 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 1.89% | +0.30% | +1.78% | |
| 19 | SRRK | Scholar Rock Holding CORP | 股票-其他 | 1.70% | +1.70% | NEW | |
| 20 | ALKS | Alkermes plc | 股票-医疗保健 | 1.66% | +1.66% | NEW | |
| 21 | ORIC | Oric Pharmaceuticals INC | 股票-其他 | 1.42% | +0.15% | -1.49% | |
| 22 | IRON | Disc Medicine INC | 股票-其他 | 1.28% | +1.28% | NEW | |
| 23 | ✓ | Helix Acquisition CORP Iii | 股票-其他 | 1.25% | +1.25% | NEW | |
| 24 | XENE | Xenon Pharmaceuticals INC | 股票-其他 | 1.17% | +1.17% | NEW | |
| 25 | CGON | Cg Oncology INC | 股票-其他 | 1.15% | -0.93% | -53.94% | |
| 26 | IMVT | Immunovant INC | 股票-其他 | 1.05% | +1.05% | NEW | |
| 27 | SYRE | Spyre Therapeutics INC | 股票-其他 | 0.96% | +0.11% | -0.60% | |
| 28 | BIIB | Biogen INC | 股票-医疗保健 | 0.95% | -0.89% | -32.42% | |
| 29 | GH | Guardant Health INC | 股票-医疗保健 | 0.93% | — | +7.18% | |
| 30 | PCVX | Vaxcyte INC | 股票-其他 | 0.86% | — | -2.56% | |
| 31 | ✓ | Uniqure NV | 股票-其他 | 0.83% | -1.57% | -30.63% | |
| 32 | SVRA | Savara INC | 股票-其他 | 0.80% | +0.80% | NEW | |
| 33 | BNTC | Benitec Biopharma INC | 股票-其他 | 0.78% | — | -1.91% | |
| 34 | ✓ | Syndax Pharmaceuticals INC | 股票-其他 | 0.76% | +0.76% | NEW | |
| 35 | ORKA | Oruka Therapeutics INC | 股票-其他 | 0.76% | +0.76% | NEW | |
| 36 | ✓ | Compugen LTD | 股票-其他 | 0.72% | — | -4.71% | |
| 37 | ✓ | Celcuity INC | 股票-其他 | 0.63% | +0.63% | NEW | |
| 38 | TRVI | Trevi Therapeutics INC | 股票-其他 | 0.62% | — | -5.56% | |
| 39 | INSM | Insmed INC | 股票-医疗保健 | 0.60% | -1.12% | -49.69% | |
| 40 | VCYT | Veracyte INC | 股票-其他 | 0.59% | -1.50% | -49.74% | |
| 41 | CERS | Cerus CORP | 股票-其他 | 0.59% | — | +12.87% | |
| 42 | CLDX | Celldex Therapeutics INC | 股票-其他 | 0.58% | — | -6.64% | |
| 43 | CCCC | C4 Therapeutics INC | 股票-其他 | 0.51% | — | -4.13% | |
| 44 | CYTK | Cytokinetics INC | 股票-医疗保健 | 0.48% | +0.48% | NEW | |
| 45 | CLYM | Climb Bio INC | 股票-其他 | 0.48% | +0.48% | NEW | |
| 46 | CMPX | Compass Therapeutics INC | 股票-其他 | 0.46% | — | -18.29% | |
| 47 | SRZN | Surrozen INC | 股票-其他 | 0.43% | — | -8.31% | |
| 48 | CTNM | Contineum Therapeutics Inc-a | 股票-其他 | 0.40% | — | -1.89% | |
| 49 | ✓ | Zura Bio LTD | 股票-其他 | 0.34% | +0.34% | NEW | |
| 50 | FULC | Fulcrum Therapeutics INC | 股票-其他 | 0.33% | — | +6.41% |
Q3 2026表现
+17.7%
近4个季度表现
+22.8%
基于可获取价格的持仓（占申报价值的62%）计算
| 季度 | 持股只数 | 总市值 | 稳定性 | 主要持股 |
|---|---|---|---|---|
| 2026-03-31 | 73 | US$9.8亿 | 76 | |
| 2025-12-31 | 68 | US$7.2亿 | 89 | |
| 2025-09-30 | 82 | US$7.4亿 | 100 | |
| 2025-06-30 | 65 | US$5.4亿 | 0 | |
| 2025-03-31 | 69 | US$4.9亿 | 100 | |
| 2024-12-31 | 61 | US$4.6亿 | 0 | |
| 2024-09-30 | 71 | US$4.5亿 | 0 | |
| 2024-06-30 | 70 | US$4.2亿 | 0 | |
| 2024-03-31 | 77 | US$3.6亿 | 0 | |
| 2023-12-31 | 67 | US$3.4亿 | 0 | |
| 2023-09-30 | 80 | US$3.3亿 | 0 | |
| 2023-06-30 | 82 | US$3.2亿 | 0 | |
| 2023-03-31 | 72 | US$2.4亿 | 0 | |
| 2022-12-31 | 90 | US$3.5亿 | 0 | |
| 2022-09-30 | 79 | US$3.0亿 | 0 | |
| 2022-06-30 | 70 | US$3.2亿 | 0 | |
| 2022-03-31 | 69 | US$2.4亿 | 0 | |
| 2021-12-31 | 71 | US$2.5亿 | 0 | |
| 2021-09-30 | 82 | US$1.8亿 | 0 | |
| 2021-06-30 | 96 | US$2.2亿 | 91 | |
| 2021-03-31 | 91 | US$1.8亿 | 79 | |
| 2020-12-31 | 85 | US$1.7亿 | — |
Silverarc Capital Management, LLC 在 2026-03-31 最显著的持仓异动： 新建仓: Spdr Series Trust; 新建仓: Zenas Biopharma INC (ZBIO); 新建仓: Scholar Rock Holding CORP (SRRK); 新建仓: Alkermes plc (ALKS); 新建仓: Disc Medicine INC (IRON).
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | ERAS | Erasca INC | +2.4% | +40.55% | 加仓 |
| 2 | ASND | Ascendis Pharma A/S | +1.5% | +153.23% | 加仓 |
| 3 | DNTH | Dianthus Therapeutics INC | +1.3% | -12.72% | 减仓 |
| 4 | GLUE | Monte Rosa Therapeutics INC | +1.1% | +94.55% | 加仓 |
| 5 | IMNM | Immunome INC | +0.8% | +64.29% | 加仓 |
| 6 | RYTM | Rhythm Pharmaceuticals INC | +0.7% | +125.08% | 加仓 |
| 7 | 4XC1 | Kalvista Pharmaceuticals INC | +0.5% | +18.51% | 加仓 |
| 8 | 260 | Centessa Pharmaceuticals-adr | +0.3% | +1.78% | 加仓 |
| 9 | SNDX | Syndax Pharmaceuticals INC | +0.2% | +38.28% | 加仓 |
| 10 | ORIC | Oric Pharmaceuticals INC | +0.2% | -1.49% | 减仓 |
| 11 | SYRE | Spyre Therapeutics INC | +0.1% | -0.60% | 减仓 |
| 12 | KOD | Kodiak Sciences INC | -0.1% | -3.05% | 减仓 |
| 13 | AARD | Aardvark Therapeutics INC | -0.5% | -88.92% | 减仓 |
| 14 | NUVL | Nuvalent Inc-a | -0.6% | +13.96% | 加仓 |
| 15 | BIIB | Biogen INC | -0.9% | -32.42% | 减仓 |
| 16 | CGON | Cg Oncology INC | -0.9% | -53.94% | 减仓 |
| 17 | COGT | Cogent Biosciences INC | -1% | +5.54% | 加仓 |
| 18 | CELC | Celcuity INC | -1% | -4.59% | 减仓 |
| 19 | INSM | Insmed INC | -1.1% | -49.69% | 减仓 |
| 20 | VCYT | Veracyte INC | -1.5% | -49.74% | 减仓 |
| 21 | ✓ | Uniqure NV | -1.6% | -30.63% | 减仓 |
| 22 | URGN | UroGen Pharma Ltd. | -2.9% | -13.56% | 减仓 |
| 23 | GUTS | Fractyl Health INC | -2.9% | -82.71% | 减仓 |
| 24 | ABVX | Abivax Sa-adr | -4.5% | -28.34% | 减仓 |
| 25 | ✓ | Spdr Series Trust | — | NEW | 新建仓 |
| 26 | ZBIO | Zenas Biopharma INC | — | NEW | 新建仓 |
| 27 | SRRK | Scholar Rock Holding CORP | — | NEW | 新建仓 |
| 28 | ALKS | Alkermes plc | — | NEW | 新建仓 |
| 29 | IRON | Disc Medicine INC | — | NEW | 新建仓 |
| 30 | ✓ | Helix Acquisition CORP Iii | — | NEW | 新建仓 |
| 31 | XENE | Xenon Pharmaceuticals INC | — | NEW | 新建仓 |
| 32 | VRDN | Viridian Therapeutics INC | — | EXIT | 清仓 |
| 33 | PFE | Pfizer INC | — | EXIT | 清仓 |
| 34 | IMVT | Immunovant INC | — | NEW | 新建仓 |
| 35 | AVTX | Avalo Therapeutics INC | — | EXIT | 清仓 |
| 36 | SVRA | Savara INC | — | NEW | 新建仓 |
| 37 | ✓ | Syndax Pharmaceuticals INC | — | NEW | 新建仓 |
| 38 | ORKA | Oruka Therapeutics INC | — | NEW | 新建仓 |
| 39 | GOSS | Gossamer Bio INC | — | EXIT | 清仓 |
| 40 | ✓ | Celcuity INC | — | NEW | 新建仓 |
| 41 | LXEO | Lexeo Therapeutics INC | — | EXIT | 清仓 |
| 42 | AMLX | Amylyx Pharmaceuticals INC | — | EXIT | 清仓 |
| 43 | SLNOEUR | Soleno Therapeutics INC | — | EXIT | 清仓 |
| 44 | OLMA | Olema Pharmaceuticals INC | — | EXIT | 清仓 |
| 45 | ✓ | Kalvista Pharmaceuticals INC | — | EXIT | 清仓 |
| 46 | CYTK | Cytokinetics INC | — | NEW | 新建仓 |
| 47 | CLYM | Climb Bio INC | — | NEW | 新建仓 |
| 48 | MLYS | Mineralys Therapeutics INC | — | EXIT | 清仓 |
| 49 | RLAY | Relay Therapeutics INC | — | EXIT | 清仓 |
| 50 | ✓ | Zura Bio LTD | — | NEW | 新建仓 |
| 季度 | 申报日期 | 类型 | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025-12-31 | 2026-02-12 | 13F-HR | 在 EDGAR 上查看 |
| 2025-09-30 | 2025-11-12 | 13F-HR | 在 EDGAR 上查看 |
| 2025-06-30 | 2025-08-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025-03-31 | 2025-05-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024-12-31 | 2025-02-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024-09-30 | 2024-11-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024-06-30 | 2024-08-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024-03-31 | 2024-05-15 | 13F-HR | 在 EDGAR 上查看 |
| 2023-12-31 | 2024-02-14 | 13F-HR | 在 EDGAR 上查看 |
| 2023-09-30 | 2023-11-13 | 13F-HR | 在 EDGAR 上查看 |
| 2023-06-30 | 2023-08-14 | 13F-HR | 在 EDGAR 上查看 |
| 2023-03-31 | 2023-05-15 | 13F-HR | 在 EDGAR 上查看 |
| 2022-12-31 | 2023-02-14 | 13F-HR | 在 EDGAR 上查看 |
| 2022-09-30 | 2022-10-28 | 13F-HR | 在 EDGAR 上查看 |
| 2022-06-30 | 2022-07-25 | 13F-HR | 在 EDGAR 上查看 |
| 2022-03-31 | 2022-05-13 | 13F-HR | 在 EDGAR 上查看 |
| 2021-12-31 | 2022-02-14 | 13F-HR | 在 EDGAR 上查看 |
| 2021-09-30 | 2021-11-15 | 13F-HR | 在 EDGAR 上查看 |
| 2021-06-30 | 2021-08-16 | 13F-HR | 在 EDGAR 上查看 |
| 2021-03-31 | 2021-05-18 | 13F-HR | 在 EDGAR 上查看 |
| 2020-12-31 | 2021-02-16 | 13F-HR | 在 EDGAR 上查看 |
资产规模相近的机构
CIK 0001143565
申报总市值
US$9.8亿
229 stks
2026-03-31
资产规模与本机构相差仅 0.0%
CIK 0001388167
申报总市值
US$9.8亿
844 stks
2024-09-30
数据过旧，未更新
资产规模与本机构相差仅 0.0%
CIK 0001794467
申报总市值
US$9.8亿
131 stks
2026-03-31
资产规模与本机构相差仅 0.1%
持仓风格相似的机构
CIK 0001802528
申报总市值
US$13.8亿
12 stks
2026-03-31
前五大持仓重叠 2/5 档，同样重仓 Dianthus Therapeutics INC
CIK 0001839435
申报总市值
US$9.0亿
29 stks
2026-03-31
前五大持仓重叠 2/5 档，同样重仓 Dianthus Therapeutics INC
CIK 0002050709
申报总市值
US$2.7亿
37 stks
2026-03-31
前五大持仓重叠 2/5 档，同样重仓 Cogent Biosciences INC